Home›HEMATOLOGY

Hematology Treatment and Management

Learn about hematology treatment strategies including medication and advanced therapies.
Explore Hematology treatment options and recovery, including chemotherapy, stem cell transplantation, and comprehensive rehabilitation programs at LIV Hospital.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

Restoring the Flow of Life

A diagnosis of a blood disorder whether it is a chronic anemia or an acute leukemia requires a treatment plan that is as dynamic as the disease itself. Blood circulates everywhere in the body; therefore, the treatment must be systemic, reaching every hidden corner where abnormal cells might reside.

At Liv Hospital, the era of “one-size-fits-all” chemotherapy is behind us. We have entered the age of Precision Hematology. By understanding the specific genetic mutations driving your disease (via our NGS labs), we can select “smart drugs” that target cancer cells while sparing healthy tissues.

Our treatment philosophy is built on Curative Intent. We combine these advanced pharmacological agents with state-of-the-art cellular therapies. For patients who have been told elsewhere that they have “run out of options,” our expertise in Haploidentical (Half-Match) Stem Cell Transplantation offers a renewed path to remission.

Chemotherapy: The Foundation of Remission

For aggressive diseases like Acute Leukemia (AML/ALL) and high-grade Lymphomas, chemotherapy remains the most potent tool to achieve rapid control. However, modern protocols are refined to maximize efficacy and minimize toxicity.

Icon LIV Hospital

Induction Therapy

front view doctor holding blood sample yt thumbnail 1280 720 LIV Hospital
  • Goal: To achieve Complete Remission (no visible cancer cells in the blood or marrow) within 30 days.
  • The Process: Patients stay in our specialized isolation unit. We administer a combination of potent drugs (such as Cytarabine and Anthracyclines) via a central venous catheter. This “wipes the slate clean,” destroying the leukemic factory in the bone marrow.
  • Support: During this phase, healthy blood counts drop temporarily. We support you with red blood cell and platelet transfusions until your marrow recovers.
Icon 1 LIV Hospital

Consolidation and Maintenance

Hematology
  • Consolidation: Once remission is achieved, we must prevent the cancer from returning. This involves further cycles of chemotherapy or a transplant.
  • Maintenance: For conditions like Acute Lymphoblastic Leukemia (ALL), patients may take lower-dose oral chemotherapy pills for 2–3 years to keep the disease suppressed (“mopping up” any microscopic residual cells).

Targeted Therapy

This is the biggest revolution in Hematology. Instead of killing all fast-growing cells (like chemo), these drugs identify specific “switches” inside the cancer cell and turn them off.

Tyrosine Kinase Inhibitors (TKIs)

  • For: Chronic Myeloid Leukemia (CML) and Ph+ ALL.
  • The Mechanism: CML is caused by a genetic fusion called BCR-ABL. Drugs like Imatinib, Dasatinib, or Nilotinib fit into this fusion protein like a key in a lock, stopping the cell from dividing.
  • The Impact: These daily pills have turned a once-fatal disease into a manageable chronic condition, similar to diabetes.

BCL-2 Inhibitors

  • For: CLL and AML.
  • The Mechanism: Cancer cells are “immortal” because they block the natural signal to die (apoptosis). Drugs like Venetoclax inhibit the BCL-2 protein, essentially removing the cancer cell’s immortality shield and causing it to self-destruct.

FLT3 and IDH Inhibitors

  • For: AML with specific mutations.
  • The Mechanism: If our genetic panel finds an FLT3 or IDH mutation, we add specific inhibitors (like Midostaurin) to the chemotherapy backbone, significantly improving survival rates.

Immunotherapy: Unleashing the Body's Army

We are moving away from toxic chemicals toward harnessing the patient’s own immune system to fight the malignancy.

Monoclonal Antibodies

  • For: Non-Hodgkin Lymphoma and CLL.
  • The Mechanism: Lab-made proteins (like Rituximab or Obinutuzumab) attach to the CD20 marker on the surface of B-cells. This acts as a flag, alerting your immune system’s “Natural Killer” cells to attack and destroy the marked cancer cells.

Bispecific T-Cell Engagers (BiTEs)

  • For: Relapsed Acute Lymphoblastic Leukemia (ALL).
  • The Mechanism: A drug (like Blinatumomab) acts like a “handcuff.” One end grabs the cancer cell, and the other end grabs a passing T-cell (immune soldier), forcing them together. The T-cell then destroys the cancer cell. This works even when standard chemo fails.

Checkpoint Inhibitors

  • For: Hodgkin Lymphoma.
  • The Mechanism: Cancer cells often put up a “Do Not Eat Me” sign (PD-L1) to hide from the immune system. Drugs like Pembrolizumab rip down this sign, exposing the cancer to an immune attack.

Get an Online Consultation with
Certified Doctors

Clinics/branches
GDPR

Related Doctors

Prof. MD. Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Assoc. Prof. MD. Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Group 346 LIV Hospital

Reviews from 9,651

4,9

Worth a look

Related Videos
Departments
Our Doctors
News

Was this article helpful?

Was this article helpful?

I didn't like it
I LIKE

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

Stem Cell Transplantation

When the bone marrow is too damaged or the cancer is too aggressive for drugs alone, we must replace the entire system. This is Hematopoietic Stem Cell Transplantation (HSCT).

Autologous Transplantation (Self-Rescue)

  • Used For: Multiple Myeloma, Lymphoma.
  • The Strategy: We collect your own healthy stem cells when the disease is controlled. We freeze them. Then, we give you a massive dose of chemotherapy to kill any remaining cancer. Finally, we thaw and re-infuse your cells to “rescue” your bone marrow and restart blood production.

Allogeneic Transplantation (Donor Replacement)

  • Used For: Acute Leukemia, Aplastic Anemia, Thalassemia.
  • The Strategy: We use stem cells from a healthy donor.
  • The “Graft-versus-Leukemia” Effect: The donor’s immune cells recognize any remaining cancer cells in your body as “foreign” and hunt them down. This biological surveillance provides the cure.

Haploidentical Transplantation (The Liv Advantage)

  • The Problem: Many patients do not have a fully matched donor sibling.
  • The Solution: We use a 50% matched donor (a parent, child, or half-matched sibling). Using advanced protocols (Post-Transplant Cyclophosphamide), we can perform these transplants with success rates comparable to full matches. Every patient has a donor.
abstract background red oil bubble water wallpaper x banner 1500 500 LIV Hospital

Treatment for Non-Malignant Disorders

Hematology is not just about cancer. We manage lifelong genetic and autoimmune conditions.

Therapeutic Apheresis (Plasma Exchange)

  • For: TTP, Sickle Cell Crisis, Hyperviscosity.
  • The Procedure: We connect the patient to a machine that separates the blood. We remove the harmful component (e.g., sticky sickle cells or auto-antibodies) and replace it with healthy plasma or red cells. This provides rapid relief from life-threatening symptoms.

Iron Chelation Therapy

  • For: Thalassemia Major and Myelodysplastic Syndrome (MDS).
  • The Issue: Frequent blood transfusions lead to iron overload, which can damage the heart and liver.
  • The Treatment: We use oral chelators (Deferasirox) or infusions to bind the excess iron and flush it out of the body, protecting vital organs.

Coagulation Factor Replacement

  • For: Hemophilia A and B.

The Strategy: We provide prophylactic (preventative) factor concentrates to prevent spontaneous bleeding into joints, allowing patients to live active lives.

The Sterile Environment

For patients undergoing intensive hematology treatment, the immune system is temporarily compromised (Neutropenia). Preventing infection is part of the treatment.

  • HEPA Filtration: Our inpatient rooms are equipped with High-Efficiency Particulate Air filters that remove 99.99% of bacteria, fungi, and dust.
  • Positive Pressure: Air flows out of the room, preventing hallway germs from entering.
  • Dietary Protocol: We provide a “low-microbial” diet (cooked foods only) to prevent food-borne infections during the critical recovery phase.

Supportive Care

We treat the side effects as aggressively as the disease.

  • Anti-Emetics: New generations of anti-nausea drugs make chemotherapy much more tolerable than in the past.
  • Pain Management: We use advanced protocols to manage mucositis (mouth sores) or bone pain, ensuring patient comfort.
  • Central Venous Access: We place PICC lines or Hickman catheters so patients do not need repeated needle sticks for blood draws or medication.

Get an Online Consultation with
Certified Doctors

Clinics/branches
GDPR

Related Doctors

Prof. MD. Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Assoc. Prof. MD. Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Group 346 LIV Hospital

Reviews from 9,651

4,9

Worth a look

Related Videos
Departments
Our Doctors
News

Was this article helpful?

Was this article helpful?

I didn't like it
I LIKE

FREQUENTLY ASKED QUESTIONS

Does chemotherapy always cause hair loss?

It depends on the drug. The intensive chemotherapy used for Acute Leukemia usually causes temporary hair loss (Alopecia). However, many “Targeted Therapies” (like Imatinib for CML or Rituximab for Lymphoma) do not cause hair loss. Your doctor will tell you what to expect based on your specific regimen.

The infusion of cells takes only about 30–60 minutes and looks like a blood transfusion. However, the entire process including conditioning chemotherapy, the transplant, and waiting for the new cells to grow (Engraftment) requires a hospital stay of roughly 3 to 5 weeks.

Thanks to modern protocols used at Liv Hospital, the success rates for Haploidentical (50% match) transplants are now statistically similar to fully matched unrelated donor transplants. This has revolutionized care, ensuring that almost no patient is turned away due to lack of a donor.

Chemotherapy can affect fertility.

  • Men: We strongly recommend Sperm Banking before starting treatment.
  • Women: Depending on the urgency, we can refer you to our IVF specialists for egg freezing. If treatment is urgent, we use medications to try to put the ovaries to “sleep” and protect them during chemo.

It is not necessarily “better,” but it is different. Immunotherapy is often less toxic to the whole body (less nausea/hair loss) but can have unique side effects (immune reactions). For many cancers, the best approach is a combination of both chemotherapy and immunotherapy (e.g., R-CHOP for Lymphoma).

Spine Hospital of Louisiana

RELATED VIDEOS

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17
liv-hospital-seeklogo
+90 530 174 28 17
Facebook-f X-twitter Instagram Youtube Linkedin-in Tiktok

How helpful was it?

helpful
GDPR
helpful
GDPR
helpful
GDPR
Contact Us
Contact Us
Medical Second Opinion